GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ono Pharmaceutical Co Ltd (OTCPK:OPHLY) » Definitions » Gross Profit

Ono Pharmaceutical Co (Ono Pharmaceutical Co) Gross Profit : $2,579 Mil (TTM As of Mar. 2024)


View and export this data going back to 2008. Start your Free Trial

What is Ono Pharmaceutical Co Gross Profit?

Ono Pharmaceutical Co's gross profit for the three months ended in Mar. 2024 was $541 Mil. Ono Pharmaceutical Co's gross profit for the trailing twelve months (TTM) ended in Mar. 2024 was $2,579 Mil.

Gross Margin % is calculated as gross profit divided by its revenue. Ono Pharmaceutical Co's gross profit for the three months ended in Mar. 2024 was $541 Mil. Ono Pharmaceutical Co's Revenue for the three months ended in Mar. 2024 was $753 Mil. Therefore, Ono Pharmaceutical Co's Gross Margin % for the quarter that ended in Mar. 2024 was 71.92%.

Ono Pharmaceutical Co had a gross margin of 71.92% for the quarter that ended in Mar. 2024 => Durable competitive advantage

During the past 13 years, the highest Gross Margin % of Ono Pharmaceutical Co was 75.39%. The lowest was 70.96%. And the median was 74.11%.


Ono Pharmaceutical Co Gross Profit Historical Data

The historical data trend for Ono Pharmaceutical Co's Gross Profit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ono Pharmaceutical Co Gross Profit Chart

Ono Pharmaceutical Co Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Gross Profit
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,981.62 2,058.08 2,258.86 2,522.17 2,506.68

Ono Pharmaceutical Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Gross Profit Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 612.66 635.58 704.14 697.96 541.36

Competitive Comparison of Ono Pharmaceutical Co's Gross Profit

For the Drug Manufacturers - General subindustry, Ono Pharmaceutical Co's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ono Pharmaceutical Co's Gross Profit Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Ono Pharmaceutical Co's Gross Profit distribution charts can be found below:

* The bar in red indicates where Ono Pharmaceutical Co's Gross Profit falls into.



Ono Pharmaceutical Co Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

Ono Pharmaceutical Co's Gross Profit for the fiscal year that ended in Mar. 2024 is calculated as

Gross Profit (A: Mar. 2024 )=Revenue - Cost of Goods Sold
=3355.204 - 848.526
=2,507

Ono Pharmaceutical Co's Gross Profit for the quarter that ended in Mar. 2024 is calculated as

Gross Profit (Q: Mar. 2024 )=Revenue - Cost of Goods Sold
=752.704 - 211.343
=541

Gross Profit for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $2,579 Mil.

Gross Profit is the numerator in the calculation of Gross Margin.

Ono Pharmaceutical Co's Gross Margin % for the quarter that ended in Mar. 2024 is calculated as

Gross Margin % (Q: Mar. 2024 )=Gross Profit (Q: Mar. 2024 ) / Revenue (Q: Mar. 2024 )
=(Revenue - Cost of Goods Sold) / Revenue
=541 / 752.704
=71.92 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Ono Pharmaceutical Co  (OTCPK:OPHLY) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Ono Pharmaceutical Co had a gross margin of 71.92% for the quarter that ended in Mar. 2024 => Durable competitive advantage


Ono Pharmaceutical Co Gross Profit Related Terms

Thank you for viewing the detailed overview of Ono Pharmaceutical Co's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.


Ono Pharmaceutical Co (Ono Pharmaceutical Co) Business Description

Traded in Other Exchanges
Address
8-2, Kyutaromachi 1-chome, Chuo-ku, Osaka, JPN, 541-8564
Ono Pharmaceutical is a drug manufacturer with a focus on drug discovery in areas of unmet medical needs. It maintains a global business in specialty pharmaceuticals. The company breaks out its revenue of goods and products into eight segments. The vast majority of Ono's revenue is derived from its circulatory and respiratory drugs, followed by its metabolic drugs and vitamins. The company also reports revenue derived from royalties. The bulk of Ono's sales are generated in Japan, followed by the rest of Asia and Europe.

Ono Pharmaceutical Co (Ono Pharmaceutical Co) Headlines